Top officials at Johnson & Johnson (NYSE: JNJ) are eager to acquire companies with technologies that could enhance their MedTech business. That was one of the big takeaways yesterday from the company’s earnings call. MedTech is rebounding well from the COVID-19 pandemic, with revenues up 5.9% year-over-year in the first quarter. The company is reaching […]
Featured
FDA warns about non-invasive prenatal screening tests
The FDA issued a warning about the risk of false results, inappropriate use and inappropriate result interpretation with prenatal tests. Non-invasive prenatal screening (NIPS) tests, also known as cell-free DNA tests or non-invasive prenatal tests (NIPT) look for signs of genetic abnormalities in a fetus by testing a sample of blood from the pregnant person. […]
Philips has another round of serious ventilator recalls
Royal Philips’ (NYSE:PHG) ventilator problems continue as the company has issued further recalls for its respiratory devices. FDA earlier this week said it was designating more Philips recalls as Class I — the most serious kind. The recalls involve all models of the Philips Respironics V60 ventilator, the V60 Plus ventilator and the V680 ventilator […]
Abbott beats The Street in Q1 as COVID-19 testing continues to drive revenue growth
Abbott (NYSE:ABT) shares are up today on first-quarter results ahead of the consensus forecast, with the company sticking by its full-year adjusted EPS projection. The Abbott Park, Illinois-based company posted profits of $2.4 billion, or $1.37 per share, on sales of $11.9 billion for the three months ended March 31, 2022, for a 36.5% bottom-line […]
Dentsply Sirona sacks its CEO
Dentsply Sirona (Nasdaq: XRAY) announced today that it has fired CEO Don Casey, who has held the corner office at the dental products and technologies company since 2018. XRAY shares were down more than 13% to $42.20 apiece by today’s close of trading. Board member John Groetelaars, who was CEO of Hillrom until its acquisition […]
How Insulet created its next-gen Omnipod 5
Insulet (NSDQ:PODD) added to its portfolio of life-changing diabetes management technologies when its Omnipod 5 received FDA clearance in January. Omnipod 5 provides easier glucose management, with no multiple daily injections, no tubes and zero fingersticks. Paired with Dexcom’s G6 continuous glucose monitoring (CGM) system, Omnipod 5 is the first tubeless, wearable, automated insulin delivery […]
Ambu makes single-use scopes available for swallowing evaluation procedures
Ambu today announced new capabilities for its single-use aScope 4 RhinoLaryngo Slim and aView 2 Advance HD monitor. The new capabilities bring Ambu single-use endoscopy to bear on fibreoptic endoscopic evaluation of swallowing (FEES) procedures, which Ambu officials take place more than 1 million times a year across key markets in North America, Europe and […]
Moderna says bivalent COVID-19 boosters could offer more robust protection against variants
Moderna (Nasdaq:MRNA) announced that its first bivalent booster vaccine candidate, mRNA-1273.211, offered superior protection against SARS-CoV-2 variants of concern compared with its first-gen mRNA-1273 vaccine. A 50-µg booster of the mRNA-1273.211 vaccine offered protection against the beta, delta and omicron variants for six months and appeared to provide similar tolerability to the FDA-approved mRNA-1273 vaccine. […]
Baxter-sponsored study supports use of hemodynamic monitoring to help predict outcomes
Baxter (NYSE:BAX) announced today that study findings supported stroke volume and cardiac monitoring for predicting patient outcomes. The Baxter-sponsored study found that monitoring stroke volume and cardiac output trends for patients with critical conditions may offer vital insight into cardiac function and aid in predicting patient outcomes, including mortality. Deerfield, Illinois-based Baxter’s study findings were […]
FDA approves IDE supplement for Virtual Incision’s miniaturized surgical robotics platform
Virtual Incision announced today that it received an FDA investigational device exemption (IDE) supplement for its MIRA platform. Lincoln, Nebraska-based Virtual Incision’s IDE supplement allows the company to complete the final stage of its clinical study for the MIRA (miniaturized in vivo robotic assistant) platform in bowel resection procedures. The company said in a news […]
Johnson & Johnson rises on mixed bag Q1, increased 2022 guidance
Johnson & Johnson (NYSE:JNJ) shares ticked up today on first-quarter results that were mixed compared to the consensus forecast. The New Brunswick, New Jersey-based company posted profits of $5.1 billion, or $1.93 per share, on sales of $23.4 billion in the first quarter for a 16.9% bottom-line slide on sales growth of nearly 5%. Adjusted […]